Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Integra Lifesciences Holdings Corp. (IART)
NASDAQ:IART
Holding IART?
Track your performance easily
IART Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$16.96 - $45.42
Previous Close$17.53
Volume857.63K
Average Volume (3M)1.50M
Market Cap
$1.36B
Enterprise Value$3.07B
Total Cash (Recent Filing)$296.90M
Total Debt (Recent Filing)$2.01B
Price to Earnings (P/E)59.4
Beta1.27
Next Earnings
Oct 23, 2024EPS Estimate
$0.39Last Dividend Ex-Date
Jul 02, 2015Dividend YieldN/A
Share Statistics
EPS (TTM)0.29
Shares Outstanding77,582,027
10 Day Avg. Volume1,105,072
30 Day Avg. Volume1,502,544
Standard Deviation0.10
R-Squared0.35
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.89
Price to Sales (P/S)0.85
Price to Cash Flow (P/CF)8.20
P/FCF Ratio31.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.98
Enterprise Value/Gross Profit3.47
Enterprise Value/Ebitda18.09
Forecast
1Y Price Target
$28.13Price Target Upside60.47% Upside
Rating ConsensusHold
Number of Analyst Covering8
Integra Lifesciences News
Bulls Say, Bears Say
Bulls Say
EarningsSecond-quarter sales were $418.2 mln, coming in ahead of 2Q24 guidance of $411 mln-$416 mln.
Growth StrategyIART has a number of areas of momentum to point to, including strong OUS growth as it looks to take its products to underpenetrated markets.
Product ManufacturingIART announced plans to restart the manufacture of PriMatrix and SurgiMend at its new Braintree manufacturing facility.
Bears Say
Financial PerformanceSignificant cuts to FY24 revenue & EPS guidance.
Management And ExpectationsThe company has done a poor job of improving its operations but an even worse job communicating these issues and setting appropriate expectations.
Operational IssuesQuality issues continue to hamper almost all aspects of IART's business and as a result shipping holds are being implemented which disrupt 3Q.
---
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
IART FAQ
What was Integra Lifesciences Holdings Corp.’s price range in the past 12 months?
Integra Lifesciences Holdings Corp. lowest stock price was $16.96 and its highest was $45.42 in the past 12 months.
What is Integra Lifesciences Holdings Corp.’s market cap?
Currently, no data Available
When is Integra Lifesciences Holdings Corp.’s upcoming earnings report date?
Integra Lifesciences Holdings Corp.’s upcoming earnings report date is Oct 23, 2024 which is in 34 days.
How were Integra Lifesciences Holdings Corp.’s earnings last quarter?
Integra Lifesciences Holdings Corp. released its earnings results on Jul 29, 2024. The company reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.623 by $0.007.
Is Integra Lifesciences Holdings Corp. overvalued?
According to Wall Street analysts Integra Lifesciences Holdings Corp.’s price is currently Undervalued.
Does Integra Lifesciences Holdings Corp. pay dividends?
Integra Lifesciences Holdings Corp. pays a Notavailable dividend of $3.18 which represents an annual dividend yield of N/A. See more information on Integra Lifesciences Holdings Corp. dividends here
What is Integra Lifesciences Holdings Corp.’s EPS estimate?
Integra Lifesciences Holdings Corp.’s EPS estimate is $0.39.
How many shares outstanding does Integra Lifesciences Holdings Corp. have?
Integra Lifesciences Holdings Corp. has 77,582,020 shares outstanding.
What happened to Integra Lifesciences Holdings Corp.’s price movement after its last earnings report?
Integra Lifesciences Holdings Corp. reported an EPS of $0.63 in its last earnings report, beating expectations of $0.623. Following the earnings report the stock price went down -19.122%.
Which hedge fund is a major shareholder of Integra Lifesciences Holdings Corp.?
Among the largest hedge funds holding Integra Lifesciences Holdings Corp.’s share is Deerfield Management Company, LP. It holds Integra Lifesciences Holdings Corp.’s shares valued at 43M.
---
Integra Lifesciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$28.13 (60.47% Upside)
$28.13 (60.47% Upside)
Hedge Fund Trend
Increased
By 173.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $25.7K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-55.34%
12-Months-Change
Fundamentals
Return on Equity
1.47%
Trailing 12-Months
Asset Growth
7.86%
Trailing 12-Months
Company Description
Integra Lifesciences Holdings Corp.
Integra LifeSciences Holdings Corp. engages in the manufacture and sale of medical instruments, devices, and equipment. It operates through the Codman Specialty Surgical, and Orthopedics and Tissue Technologies segments. The Codman Specialty Surgical segment refers to the company's neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and precision tools and instruments business, which sells instrument patterns and surgical and lighting products to hospitals, surgery centers, and dental, podiatry, and veterinary offices. The Orthopedics and Tissue Technologies segment includes offerings such as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.
---
IART Company Deck
---
IART Earnings Call
Q2 2024
0:00 / 0:00
---
IART Stock 12 Month Forecast
Average Price Target
$28.13
▲(60.47% Upside)
Technical Analysis
Best Analysts Covering IART
1 Year
1 Year Success Rate
8/8 ratings generated profit
1 Year Average Return
+38.27%
assigned a sell rating 2 months ago
Copying Craig Bijou's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +38.27% per trade.
---